Prostate cancer vaccines in combination with additional treatment modalities

被引：15

作者：

Uhlman, Matthew A. ^{[1
]}

Bing, Megan T. ^{[1
]}

Lubaroff, David M. ^{[1
,2
,3
]}

机构：

[1] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA

[2] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA

[3] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA

来源：

IMMUNOLOGIC RESEARCH | 2014年 / 59卷 / 1-3期

关键词：

Prostate cancer; Immunotherapy; Cancer vaccines; Combination therapy; AUTOLOGOUS CELLULAR IMMUNOTHERAPY; SIPULEUCEL-T; IMMUNOSTIMULATORY PROPERTIES; ANTITUMOR-ACTIVITY; INCREASED SURVIVAL; RADIATION-THERAPY; ACID-PHOSPHATASE; DOUBLE-BLIND; PHASE-II; DOCETAXEL;

D O I：

10.1007/s12026-014-8532-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunotherapy has been investigated in both preclinical studies and clinical trials as a new therapy for prostate cancer. Vaccines, including those that utilize dendritic cells, viruses, or DNA, immunize against prostate-specific antigen and prostatic acid phosphatase. The vaccines have long been studied as monotherapy for the cancer, but increasingly more trials have been initiated in combination with other modalities. These include radiation, chemotherapy, and androgen deprivation therapy. This review describes and discusses the various combinations of vaccine immunotherapies.

引用

页码：236 / 242

页数：7

共 50 条

[41] Vaccines as treatments for prostate cancer
Ichwaku Rastogi
Anusha Muralidhar
Douglas G. McNeel
Nature Reviews Urology, 2023, 20 : 544 - 559
[42] Advances in imaging modalities in prostate cancer
Bouchelouche, Kirsten
Turkbey, Baris
Choyke, Peter L.
CURRENT OPINION IN ONCOLOGY, 2015, 27 (03) : 224 - 231
[43] Update on Prostate Cancer Vaccines
Drake, Charles G.
CANCER JOURNAL, 2011, 17 (05): : 294 - 299
[44] DNA vaccines for prostate cancer
Zahm, Christopher D.
Colluru, Viswa Teja
McNeel, Douglas G.
PHARMACOLOGY & THERAPEUTICS, 2017, 174 : 27 - 42
[45] Treatment modalities for Maori and New Zealand European men with localised prostate cancer
Obertova, Zuzana
Lawrenson, Ross
Scott, Nina
Holmes, Michael
Brown, Charis
Lao, Chunhuan
Tyrie, Leanne
Gilling, Peter
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (04) : 814 - 820
[46] Clinical-Prostate cancer Functional outcomes after prostate cancer treatment: A comparison between single and multiple modalities
Muise, Alexandra
Pan, Michael M.
Rose, Brent
Buckley, Jill C.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (02) : 104.e1 - 104.e9
[47] Current and emerging treatment modalities for metastatic castration-resistant prostate cancer
Bracarda, Sergio
Logothetis, Christopher
Sternberg, Cora N.
Oudard, Stephane
BJU INTERNATIONAL, 2011, 107 : 13 - 20
[48] A comparison of prostate cancer treatment modalities between academic centers and private hospitals
Zhao, Philip T.
DiPaola, Robert S.
Weiss, Robert E.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S130 - S130
[49] Vaccines as treatment strategies for relapsed prostate cancer - Approaches for induction of immunity
Slovin, SR
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2001, 15 (03) : 477 - +
[50] Prostate Cancer: Biology, Incidence, Detection Methods, Treatment Methods, and Vaccines
Bartzatt, Ronald
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (10) : 847 - 854

← 1 2 3 4 5 →